Edition:
United Kingdom

People: Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

713.00GBp
3:58pm BST
Change (% chg)

-17.00 (-2.33%)
Prev Close
730.00
Open
760.00
Day's High
760.00
Day's Low
713.00
Volume
24,289
Avg. Vol
72,169
52-wk High
1,064.38
52-wk Low
575.32

Dawson, John 

Mr. John Dawson serves as Chief Executive Officer, Executive Director of Oxford BioMedica Plc. From 1996 to 2007, Mr Dawson held senior management positions in the European operations of Cephalon Inc. including, from 2005, a management board position as Chief Financial Officer and Head of Business Development, Europe. In his time at Cephalon he led many of the deals that built the European business to over 1,000 people, taking the business from having no sales in 1998 to revenue of several hundred million US dollars. In 2005, Mr Dawson led the US$360 million acquisition of Zeneus by Cephalon. Between 1991 and 1996 he was Director of Finance and Administration of Serono Laboratories (UK) Limited. Mr Dawson is a non-Executive director of Paion AG.

Basic Compensation

Total Annual Compensation, GBP 647,000
Restricted Stock Award, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 33,000
Fiscal Year Total, GBP 680,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --